Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A simple solution for complicated pleural effusions.

Sudish C Murthy1, Ikenna Okereke, David P Mason

  • 1Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio 44195, USA. Murthys1@ccf.org

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|April 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Commentary: The evolving nature of treatment strategies for esophageal cancer.

The Journal of thoracic and cardiovascular surgery·2026
Same author

PneumoScore: A Novel Risk Prediction Model for 90-Day Mortality after Lung Resection.

Annals of surgical oncology·2026
Same author

Hidden in plain sight: a narrative review on environmental exposures and the fight against mesothelioma.

Journal of thoracic disease·2026
Same author

Clustered Symptom Trajectories After Pulmonary Resection: Implications for Risk Stratification and Recovery.

Annals of surgical oncology·2026
Same author

Management of debilitating bile reflux after esophagectomy with Roux-en-Y diversion.

JTCVS techniques·2025
Same author

When the gold standard fails: Propensity-matched comparison of peroral endoscopic myotomy after Heller myotomy versus index peroral endoscopic myotomy.

The Journal of thoracic and cardiovascular surgery·2025
Same journal

Obesity Promotes Lung Carcinogenesis Through Airway Immune Dysfunction.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same journal

Corrigendum to 'The Ninth Edition Staging Project Publications' [Journal of Thoracic Oncology (2022-2024)].

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same journal

Brief Report: Aumolertinib as a Switch Therapy in Osimertinib-Intolerant NSCLC: The ACTIVE Trial.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same journal

Brief Report: Proposed clinical trial guidelines based on clinicopathological heterogeneity of metastatic pulmonary large cell neuroendocrine carcinoma (LCNEC).

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same journal

Corrigendum to 'Patient-Reported Outcomes With Consolidation Durvalumab Versus Placebo After Concurrent Chemoradiotherapy in Limited-Stage SCLC: Results From the Phase 3 ADRIATIC Trial' [Journal of Thoracic Oncology volume 21 issue 6 (2026) 103564].

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same journal

ctDNA based MRD detection in stage III NSCLC treated with chemoradiotherapy and durvalumab.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
See all related articles

PleurX catheters offer a safe and effective solution for managing complicated pleural effusions, providing symptom relief and reducing the need for reintervention in patients with limited palliative options.

Area of Science:

  • Pulmonology
  • Thoracic Surgery
  • Palliative Care

Background:

  • Complicated pleural effusions present management challenges with conventional methods.
  • PleurX catheters offer a potential alternative for these difficult cases.

Purpose of the Study:

  • To review the safety, efficacy, and durability of PleurX catheters for complicated pleural effusions.
  • To identify patient populations who may benefit from this intervention.

Main Methods:

  • A registry of 58 patients (63 catheters) with complicated pleural effusions was analyzed.
  • Patients typically had poor performance status or failed standard therapies.
  • Data were collected via medical record review, with survival and reintervention estimated using Kaplan-Meier methods.

Related Experiment Videos

Main Results:

  • Catheter-related complications occurred in 7% of patients; no procedure-related mortalities.
  • 95% freedom from reintervention for effusion management was achieved.
  • 86% of patients experienced significant dyspnea relief, with catheters functional up to 330 days.

Conclusions:

  • PleurX catheters are a safe, effective, and durable option for complicated pleural effusions.
  • They represent an attractive alternative for patients with limited palliative choices.
  • The study suggests considering PleurX catheters as a first-line therapy in selected patients.